Evidence map›Paper›PMID 30650361›Full record

ArticleCell reports2019

Rbf Activates the Myogenic Transcriptional Program to Promote Skeletal Muscle Differentiation.

Maria Paula Zappia, Alice Rogers, Abul B M M K Islam, Maxim V Frolov

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The role of inner nuclear membrane protein emerin in myogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Organismal landscape of clock cells and circadian gene expression inbioRxiv : the preprint server for biology · 2023
    Article
  12. E2F regulation of theProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Refining theAnimals : an open access journal from MDPI · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Maria Paula ZappiaDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland Avenue, Chicago, IL 60607, USA.
Alice RogersDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland Avenue, Chicago, IL 60607, USA.
Abul B M M K IslamDepartment of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka 1000, Bangladesh.
Maxim V FrolovDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland Avenue, Chicago, IL 60607, USA. Electronic address: mfrolov@uic.edu.
Ashland (United States) · USUniversity of Dhaka · BDUniversity of Illinois Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
DROSOPHILA GENOMICS RESOURCE CENTERP40OD010949 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Andrew Zelhof · 2012 to 2026
$9.4M
Rb and Hippo tumor suppressor pathways in differentiationR01GM093827 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FROLOV, MAXIM · 2011 to 2018
$2.2M
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathwayR01GM110018 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FROLOV, MAXIM · 2015 to 2018
$1.3M
NCI NIH HHS P30 CA014599NIGMS NIH HHS R01 GM093827NIGMS NIH HHS R01 GM110018NIH HHS P40 OD010949NIH HHS P40 OD018537
6 · The paper itself

Abstract

The importance of the retinoblastoma tumor suppressor protein pRB in cell cycle control is well established. However, less is known about its role in differentiation during animal development. Here, we investigated the role of Rbf, the Drosophila pRB homolog, in adult skeletal muscles. We found that the depletion of Rbf severely reduced muscle growth and altered myofibrillogenesis but only minimally affected myoblast proliferation. We identified an Rbf-dependent transcriptional program in late muscle development that is distinct from the canonical role of Rbf in cell cycle control. Unexpectedly, Rbf acts as a transcriptional activator of the myogenic and metabolic genes in the growing muscles. The genomic regions bound by Rbf contained the binding sites of several factors that genetically interacted with Rbf by modulating Rbf-dependent phenotype. Thus, our results reveal a distinctive role for Rbf as a direct activator of the myogenic transcriptional program that drives late muscle differentiation.

Indexed as

AnimalsCell DifferentiationDrosophilaDrosophila ProteinsMuscle DevelopmentMuscle, SkeletalRetinoblastoma ProteinTranscription FactorsDrosophila ProteinsRbf protein, DrosophilaRetinoblastoma ProteinTranscription FactorsdevelopmentdifferentiationDrosophilaE2FgrowthmusclemyogenesispRBRbftranscriptional program

Identifiers

PMID30650361
PMCPMC6344057
OpenAlexW2911144414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.